Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-10
DOI
10.1038/s41467-021-27674-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
- (2021) Anthony T. Tan et al. Cell Reports
- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
- (2021) Elizabeth M. Anderson et al. CELL
- CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses
- (2021) Katie E. Lineburg et al. IMMUNITY
- CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
- (2021) Thi H.O. Nguyen et al. IMMUNITY
- T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
- (2021) Ane Ogbe et al. Nature Communications
- A human coronavirus evolves antigenically to escape antibody immunity
- (2021) Rachel T. Eguia et al. PLoS Pathogens
- Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
- (2021) Hans-Georg Rammensee et al. Vaccines
- Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control
- (2021) Aileen G. Rowan et al. JOURNAL OF VIROLOGICAL METHODS
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan
- (2020) Arnold S Monto et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2, most of which are not located in the Spike protein
- (2020) Andrew P. Ferretti et al. IMMUNITY
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
- (2020) Annika Nelde et al. NATURE IMMUNOLOGY
- Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection
- (2020) Maximillian S. Habibi et al. SCIENCE
- Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
- (2020) Petra Bacher et al. IMMUNITY
- Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
- (2020) Giulietta Saletti et al. Scientific Reports
- TheHLA-net GENE[RATE]pipeline for effective HLA data analysis and its application to 145 population samples from Europe and neighbouring areas
- (2014) J. M. Nunes et al. TISSUE ANTIGENS
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started